Merck
  • 主页
  • 查找结果
  • An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.

An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.

International journal of cancer (2014-05-07)
Yong Jin An, Hye Rim Cho, Tae Min Kim, Bhumsuk Keam, Jin Wook Kim, He Wen, Chul-Kee Park, Se-Hoon Lee, Seock-Ah Im, Jeong Eun Kim, Seung Hong Choi, Sunghyouk Park
摘要

Leptomeningeal carcinomatosis (LC) is a metastatic cancer invading the central nervous system (CNS). We previously reported a metabolomic diagnostic approach as tested on an animal model and compared with current modalities. Here, we provide a proof of concept by applying it to human LC originating from lung cancer, the most common cause of CNS metastasis. Cerebrospinal fluid from LC (n = 26) and normal groups (n = 41) were obtained, and the diagnosis was established with clinical signs, cytology, MRI and biochemical tests. The cytology on the CSF, the current gold standard, exhibited 69% sensitivity (~100% specificity) from the first round of CSF tapping. In comparison, the nuclear magnetic resonance spectra on the CSF showed a clear difference in the metabolic profile between the LC and normal groups. Multivariate analysis and cross-validation yielded the diagnostic sensitivity of 92%, the specificity of 96% and the area under the curve (AUC) of 0.991. Further spectral and statistical analysis identified myo-inositol (p < 5 × 10(-14)), creatine (p < 7 × 10(-8)), lactate (p < 9 × 10(-4)), alanine (p < 7.9 × 10(-3)) and citrate (p < 3 × 10(-4)) as the most contributory metabolites, whose combination exhibited an receiver-operating characteristic diagnostic AUC of 0.996. In addition, the metabolic profile could be correlated with the grading of radiological leptomeningeal enhancement (R(2) = 0.3881 and p = 6.66 × 10(-4)), suggesting its potential utility in grading LC. Overall, we propose that the metabolomic approach might augment current diagnostic modalities for LC, the accurate diagnosis of which remains a challenge.

材料
货号
品牌
产品描述

Sigma-Aldrich
柠檬酸, ACS reagent, ≥99.5%
Sigma-Aldrich
柠檬酸, 99%
Sigma-Aldrich
L-丙氨酸, ≥98% (TLC)
Sigma-Aldrich
柠檬酸, meets analytical specification of Ph. Eur., BP, USP, E330, anhydrous, 99.5-100.5% (based on anhydrous substance)
Sigma-Aldrich
柠檬酸, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Supelco
柠檬酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
一水肌酸, anhydrous
Sigma-Aldrich
柠檬酸, anhydrous, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
L-丙氨酸, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-丙氨酸, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
柠檬酸, BioUltra, anhydrous, ≥99.5% (T)
Sigma-Aldrich
L-丙氨酸, ≥99%
Supelco
柠檬酸, analytical standard
USP
柠檬酸, United States Pharmacopeia (USP) Reference Standard
Supelco
L-丙氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-丙氨酸, ≥99.0% (NT)
Supelco
柠檬酸, certified reference material, TraceCERT®
丙氨酸, European Pharmacopoeia (EP) Reference Standard
柠檬酸, anhydrous, European Pharmacopoeia (EP) Reference Standard
Supelco
L-丙氨酸, certified reference material, TraceCERT®
Sigma-Aldrich
L-Alanine-12C3, 99.9 atom % 12C